SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.

As of 05/24/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  02/01/2018
Outstanding shares:  23,126,804
Average volume:  11,248
Market cap:   $143,270,551
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   81.84
PB ratio:   2.48
PS ratio:   4.69
Return on equity:   3.37%
Net income %:   5.52%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy